Literature DB >> 4463951

Purification and specificity of a human microsomal epoxide hydratase.

F Oesch.   

Abstract

Epoxide hydratase was solubilized from human liver microsomal fractions and purified to an extent where the specific activity was 40-fold greater than that of the liver homogenate. Combination of homogenate and purified preparation showed that the increase in activity was not due to the removal of an inhibitor. Monosubstituted oxiranes with a lipophilic substituent larger than an ethyl group (isopropyl, t-butyl, n-hexyl, phenyl) readily interacted as substrates or inhibitors with this purified human epoxide hydratase, whereas those with a small substituent (methyl, ethyl, vinyl) were inactive, probably reflecting greater affinity of the former epoxides owing to lipophilic binding sites near the active site of the enzyme. In a series of oxiranes having a lipophilic substituent of sufficient size (styrene oxides), monosubstituted as well as 1,1- and cis-1,2-disubstituted oxiranes readily served as substrates or inhibitors of the enzyme, but not the trans-1,2-disubstituted, tri- or tetra-substituted oxiranes. trans-Substitution at the oxirane ring apparently prevents access of the oxirane ring to the active site by steric hindrance. Epoxide hydratase was also solubilized from microsomal fractions of rat and guinea-pig liver and purified by the same procedure. Structural requirements for effective interaction of substrates, inhibitors and activators were qualitatively identical for epoxide hydratase from the three sources. However, several quantitative differences were observed. Thus human hepatic epoxide hydratase seems to be very similar to, although not identical with, the enzyme from guinea pig or rat. Studies with epoxide hydratase from the latter two species therefore appear to be significant with respect to man. In addition, knowledge of structural requirements for epoxides to serve as substrates for human epoxide hydratase may prove useful for drug design. Compounds which need aromatic or olefinic moieties for their desired effect would not be expected to lead to accumulation of epoxides if their structure was such as to allow for a metabolically produced epoxide to be rapidly consumed by epoxide hydratase.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4463951      PMCID: PMC1166253          DOI: 10.1042/bj1390077

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Epoxides as microsomal metabolites of polycyclic hydrocarbons.

Authors:  P L. Grover; A Hewer; P Sims
Journal:  FEBS Lett       Date:  1971-10-15       Impact factor: 4.124

2.  Conversion of naphthalene to trans-naphthalene dihydrodiol: evidence for the presence of a coupled aryl monooxygenase-epoxide hydrase system in hepatic microsomes.

Authors:  F Oesch; J Daly
Journal:  Biochem Biophys Res Commun       Date:  1972-02-25       Impact factor: 3.575

3.  Substrate specificity of hepatic epoxide hydrase in microsomes and in a purified preparation: evidence for homologous enzymes.

Authors:  F Oesch; D M Jerina; J W Daly
Journal:  Arch Biochem Biophys       Date:  1971-05       Impact factor: 4.013

4.  Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors.

Authors:  F Oesch; N Kaubisch; D M Jerina; J W Daly
Journal:  Biochemistry       Date:  1971-12-21       Impact factor: 3.162

5.  Acetone enhancement of microsomal aniline para-hydroxylase activity.

Authors:  M W Anders
Journal:  Arch Biochem Biophys       Date:  1968-07       Impact factor: 4.013

6.  A simple radiometric assay for microsomal aryl hydroxylase activity.

Authors:  J W Daly
Journal:  Anal Biochem       Date:  1970-02       Impact factor: 3.365

7.  Carcnogenicity of epoxides, lactones, and peroxy compounds. VI. Structure and carcinogenic activity.

Authors:  B L Van Duuren; L Langseth; B M Goldschmidt; L Orris
Journal:  J Natl Cancer Inst       Date:  1967-12       Impact factor: 13.506

8.  Mutagenicity to mammalian cells of epoxides and other derivatives of polycyclic hydrocarbons.

Authors:  E Huberman; L Aspiras; C Heidelberger; P L Grover; P Sims
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

9.  Alkylation by propylene oxide of deoxyribonucleic acid, adenine, guanosine and deoxyguanylic acid.

Authors:  P D Lawley; M Jarman
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

10.  The role of arene oxide-oxepin systems in the metabolism of aromatic substrates. 3. Formation of 1,2-naphthalene oxide from naphthalene by liver microsomes.

Authors:  D M Jerina; J W Daly; B Witkop; P Zaltzman-Nirenberg; S Udenfriend
Journal:  J Am Chem Soc       Date:  1968-11-06       Impact factor: 15.419

View more
  24 in total

1.  Dependency of the in vitro stabilization of differentiated functions in liver parenchymal cells on the type of cell line used for co-culture.

Authors:  D Utesch; F Oesch
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

2.  Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs.

Authors:  F Oesch; R Hartmann; C Timms; M Strolin-Benedetti; P Dostert; W Wörner; L Schladt
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle.

Authors:  Simone L Popp; Ina S Abele; Miriam B Buck; Matthias B Stope; Leen J Blok; Payman Hanifi-Moghaddam; Curt W Burger; Peter Fritz; Cornelius Knabbe
Journal:  J Mol Histol       Date:  2010-04-13       Impact factor: 2.611

4.  Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites.

Authors:  F Oesch; D Raphael; H Schwind; H R Glatt
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

5.  Inactivation of electrophilic metabolites by glutathione S-transferases and limitation of the system due to subcellular localization.

Authors:  H Glatt; F Oesch
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

6.  Induction of benzo (a)pyrene monooxygenase in fish and the Salmonella test as a tool for detecting mutagenic/carcinogenic xenobiotics in the aquatic environment.

Authors:  B Kurelec; Z Matijasevic; M Rijavec; M Alacevic; S Britvic; W E Müller; R K Zahn
Journal:  Bull Environ Contam Toxicol       Date:  1979-04       Impact factor: 2.151

7.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

Authors:  D Harding; S Fournel-Gigleux; M R Jackson; B Burchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Influence of a prolonged treatment with disulfiram and D(-)penicillamine on nitrosodiethylamine-induced biological and biochemical effects in rats. I. Investigations on the drug metabolizing system.

Authors:  B Bertram; E Frei; H R Scherf; J Schuhmacher; A M Tacchi; M Wiessler
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

9.  Enzymatic Mechanisms Involved in Phenanthrene Degradation by the White Rot Fungus Pleurotus ostreatus.

Authors:  L Bezalel; Y Hadar; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

10.  Metabolism of [14C]diethylstilboestrol epoxide by rat liver in vitro.

Authors:  P H Jellinck; J H Bowen
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.